SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Zoracles

A sharp rally in low-cap ZORA, accompanied by higher volume, has prompted traders to discuss a possible technical breakout and speculative short squeeze tied to sizable futures positioning. The community is divided between bullish accumulation and creator/attention-market utility narratives versus warnings that the move may be a temporary pump-and-dump or reflect broader Bitcoin-driven volatility.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Speculation that SK Hynix could become a major Intel Foundry customer for advanced HBM base-die production is driving attention, alongside hopes for additional 14A foundry contracts and a potential Nvidia partnership. Traders are largely bullish on the possible customer wins and Intels AI-manufacturing outlook, though some caution that the SK Hynix talks remain unconfirmed and could become a buy the rumor, sell the news event.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Attention centers on the still-unconfirmed 80th death event in SELLASs Phase 3 REGAL AML trial, which would trigger final analysis and eventual topline results. Bullish traders view the prolonged event accrual and favorable pharmaceutical-industry comments as signs of durable GPS benefit, while skeptics point to midtrial dosing changes, censoring, and potential trial-design or statistical concerns.

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Arcturus Therapeutics Holdings Inc

Attention is centered on a broader mRNA-sector rally after Modernas reported cancer-vaccine success, with traders treating Arcturus as a sympathy play and highlighting its sa-mRNA/LUNAR platform and therapeutic pipeline. Bullish participants also point to technical momentum and possible short covering, while skeptics argue the move is largely speculative because ARCTs clinical programs remain unproven.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

High-level discussions with Indian officials about potential collaboration on solid-state batteries and local manufacturing are fueling speculation about new partnerships and market opportunities. Traders remain divided, with bulls anticipating licensing, customer, and Eagle Line scaling milestones while skeptics focus on the lack of externally verifiable production data, delayed commercialization, and insider selling.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Visas monitoring of Hims & Hers over elevated credit-card disputes tied to weight-loss memberships is driving the selloff, with traders also debating the impact of ongoing FTC scrutiny. Bulls view the reaction as overblown and continue buying dips, while bears warn the issues could hurt customer confidence and require changes to the business.

ProShares Trust II - ProShares Ultra Bloomberg Crude Oil 2x Shares

ProShares Ultra Bloomberg Crude Oil

Expectations for U.S.-Iran de-escalation and a reopening of the Strait of Hormuz are driving attention to crude oil and UCO, with traders debating whether restored shipping flows and rising global supply will pressure prices. Bulls remain focused on potential disruptions and constrained transport, while bearish participants point to oversupply, inventory builds, and weakening demand.

Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.

Agenus Inc

Positive NEST Phase 2 data for BOT+BAL in neoadjuvant MSS/pMMR colorectal cancershowing deep pathologic responses and no observed recurrenceshas fueled attention, alongside the BATTMAN-to-ROBBIN Phase 3 pivot and institutional financing. Traders see the results and funding as evidence of improving execution and a potential approval path, while skeptics cite the small, non-randomized studies, lengthy timeline, and warrant or ATM dilution.

ARK ETF Trust - ARK Innovation ETF

ARK Innovation ETF

Reported ARK Invest accumulation of SpaceX shares, including a sizable allocation in ARKK, has become the main focus, reinforcing the ETFs concentrated exposure to high-growth space and technology themes. Traders are divided between viewing the purchases as conviction in long-term innovation and criticizing the timing, valuation risk, and ARKKs prolonged underperformance.

DoorDash, Inc. engages in the design, development, and operation of a food delivery and logistics platform. It serves consumers in the United States, Canada, and Australia. The company was founded by Andy Fang, Tony Xu, Stanley Tang, and Evan Moore on January 12, 2013 and is headquartered in San Francisco, CA.

DoorDash Inc - Ordinary Shares - Class A

DoorDashs quarterly results, including strong order and revenue growth, an adjusted EBITDA beat, and upbeat forward guidance, are driving bullish momentum and renewed calls activity. Traders remain divided, with supporters citing expanding grocery, retail, logistics, and autonomous-delivery opportunities while skeptics point to the elevated valuation, margin concerns, and risk of a post-earnings pullback.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is headed towards a positive week. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Fundamentals

Info